Home >
Medicine Info >
Olmeglare A (5/20 mg) Tablet
Loading interface...

Olmeglare A (5/20 mg) Tablet

Manufactured byIpca Laboratories Pvt. Ltd.
ContainsAmlodipine (5 mg) + Olmesartan (20 mg)
Description
Olmeglare A (5/20 mg) Tablet is a combination of Amlodipine and Olmesartan. It is used in the treatment of high blood pressure. This medicine works by relaxing your heart muscles and blood vessels. This promotes the smooth flow of blood and makes it easier for your heart to pump blood throughout the body. Olmeglare A (5/20 mg) Tablet shows side effects like swelling in your ankles or feet, headache, sleepiness, dizziness, nausea, and upset stomach. Usually, these side effects are temporary. Consult your doctor if any of these side effects do not resolve with time or get worse. Avoid taking this medicine if you are allergic to it. Olmeglare A (5/20 mg) Tablet can be taken with or without food. The dose will be decided by your doctor depending on your blood pressure level. Take this medicine at the same time every day to maintain a constant level in the blood. Avoid the discontinuation of this medicine without your doctor's consultation as it can cause your blood pressure to rise, thereby increasing the risk of heart attack and stroke (a condition that occurs due to reduced blood supply to the brain). Olmeglare A (5/20 mg) Tablet should be used with caution if you have kidney, liver, or heart problems. Inform your doctor if you are taking any other medicine before starting the treatment. Olmeglare A (5/20 mg) Tablet is not recommended for use in children below 18 years of age. Consult your doctor if you are pregnant, planning a pregnancy, or are breastfeeding.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Side effects

Major & minor side effects for Olmeglare A (5/20 mg) Tablet

  • Body pain
  • Headache
  • Chills
  • Nasal congestion
  • Unusual tiredness and weakness
  • Blood in urine
  • Joint pain
  • Swelling of feet or lower legs
  • Diarrhoea
  • Dry mouth
  • Increased urination
  • Skin rash
  • Difficulty in breathing
  • Increased heartbeat
  • Upset stomach

Uses of Olmeglare A (5/20 mg) Tablet

What is it prescribed for?

  • Hypertension
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time taken for Olmeglare A (5/20 mg) Tablet to start its action is not known.
  • How long do the effects of this medicine last?
    The effect of Olmeglare A (5/20 mg) Tablet lasts for an average duration of 24 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Avoid consumption of alcohol while you are taking Olmeglare A (5/20 mg) Tablet as it may further lower your blood pressure and make you feel dizzy or lightheaded.
  • Is this a habit forming medicine?
    Olmeglare A (5/20 mg) Tablet has no habit-forming tendency.
  • Can this medicine be taken during pregnancy?
    Olmeglare A (5/20 mg) Tablet is not recommended for use during pregnancy as it can harm your foetus.
  • Can this medicine be taken while breast-feeding?
    Olmeglare A (5/20 mg) Tablet is not recommended for use while breastfeeding as it is not known if this medicine passes into breastmilk. Consult your doctor if you are breastfeeding.

Allergy

Avoid taking Olmeglare A (5/20 mg) Tablet if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling of the face/tongue/throat, breathing difficulty, etc.

Aliskiren

Combined use of Olmeglare A (5/20 mg) Tablet and Aliskiren (a medicine used to reduce blood pressure) is not recommended if you have diabetes (high blood sugar levels) and/or moderate to severe kidney impairment as it may increase the risk of kidney damage.
Warnings for special population

Pregnancy

Olmeglare A (5/20 mg) Tablet is not recommended for use during pregnancy as it can harm your foetus.

Breast-feeding

Olmeglare A (5/20 mg) Tablet is not recommended for use while breastfeeding as it is not known if this medicine passes into breastmilk. Consult your doctor if you are breastfeeding.
General warnings

Aortic stenosis

Aortic stenosis is the narrowing of the valves of the heart that regulates the blood flow from the heart to the body. Olmeglare A (5/20 mg) Tablet should be used with caution if you have aortic stenosis. This medicine affects the contraction of the heart and will worsen your condition.

Hyperkalaemia

Olmeglare A (5/20 mg) Tablet should be used with caution as it may cause hyperkalaemia (high potassium levels in the blood). Your doctor may suggest a test to monitor the potassium levels regularly. Avoid potassium-rich foods (potatoes, bananas) and potassium supplements during treatment with this medicine.

Use in children

Olmeglare A (5/20 mg) Tablet is not recommended for use in children and adolescents less than 18 years of age as the safety and efficacy of use are not clinically established.

Driving and operating machines

Olmeglare A (5/20 mg) Tablet may cause dizziness and a decrease in blood pressure. Avoid performing activities that require high mental alertness like driving vehicles or operating machines if you experience such symptoms.

Kidney problems

Olmeglare A (5/20 mg) Tablet should be used with caution if you have kidney problems as this medicine may alter kidney functions. Your doctor may suggest tests to closely monitor your kidney function or adjust the dose based on your clinical condition.

Liver impairment

Olmeglare A (5/20 mg) Tablet is broken down in the liver. Hence, this medicine should be used with caution if you have liver problems as it may increase the risk of liver damage. Your doctor may suggest tests to monitor your liver functions and/or recommend dose adjustments based on your clinical condition.

Hypotension

Olmeglare A (5/20 mg) Tablet should be used with caution as it may cause symptomatic hypotension (low blood pressure), especially if you have volume depletion (excess loss of salt and fluid from the body) or if you are treated with high-dose diuretics (medication that increases the removal of water and salt from the body via urine). Your doctor may correct this condition before initiating treatment with Olmeglare A (5/20 mg) Tablet.

Missed Dose

If you miss a dose of Olmeglare A (5/20 mg) Tablet, take it as soon as you remember. If it is time for your next scheduled dose, then skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Never take more than the prescribed dose of Olmeglare A (5/20 mg) Tablet. If you suspect that you might have taken an overdose of this medicine, seek immediate medical attention.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Avoid consumption of alcohol while you are taking Olmeglare A (5/20 mg) Tablet as it may further lower your blood pressure and make you feel dizzy or lightheaded.
Interaction with Medicine

Dexamethasone

Itraconazole

Rifampicin

Insulin

Diclofenac

Disease interactions

Cardiogenic shock

Olmeglare A (5/20 mg) Tablet is not recommended for use in case of cardiogenic shock (a life-threatening situation in which your heart suddenly stops pumping enough blood to the body) as it may worsen your condition.

Congestive heart failure

Olmeglare A (5/20 mg) Tablet should be used with caution if you have congestive heart failure (a condition in which your heart is unable to pump a sufficient amount of blood) due to the increased risk of kidney damage and worsening of your condition. Consult your doctor before taking this medicine.
Food interactions
Consumption of grapefruit juice is not recommended during treatment with Olmeglare A (5/20 mg) Tablet as grapefruit juice can increase the absorption of this medicine in your body. This could lead to excessive lowering of your blood pressure and increased risk of side effects.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take Olmeglare A (5/20 mg) Tablet with or without food. Do not break chew or crush the tablet. It may increase the level of potassium in the blood. Avoid taking potassium supplements and potassium-rich foods such as bananas and broccoli. Olmeglare A (5/20 mg) Tablet may cause swelling in your ankles and feet, therefore, avoid sitting for long hours and try raising your legs on a low stool when you are sitting. Avoid driving vehicles or operating machines and rise up slowly from a sitting or lying position if you feel dizzy during treatment with Olmeglare A (5/20 mg) Tablet.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
Olmeglare A (5/20 mg) Tablet is a combination of Amlodipine and Olmesartan. Amlodipine works by relaxing your heart muscles and blood vessels so that blood can flow more easily. Olmesartan relaxes and widens your blood vessels. This lowers your blood pressure and makes it easier for your heart to pump blood throughout your body.
Legal Status

Approved

Approved

Approved

Unknown

Classification

Category

Angiotensin II inhibitors with calcium channel blockers, Antihypertensive combinations

Schedule

Schedule H

Dailymed.nlm.nih.gov. 2021. DailyMed - AMLODIPINE AND OLMESARTAN MEDOXOMIL tablet. [online] Available at: < [Accessed 1 October 2021].

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c1204fbe-d086-43cf-bbaa-efec9cd0487c>

Medicines.org.uk. 2021. Sevikar 20 mg/5 mg, 40 mg/5 mg, 40 mg/10 mg Film-Coated Tablets - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 1 October 2021].

https://www.medicines.org.uk/emc/medicine/21656>

Drugs, H., 2021. Amlodipine: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 1 October 2021].

https://medlineplus.gov/druginfo/meds/a692044.html>

Medicines.org.uk. 2021. Olmesartan 10mg Film-coated Tablets - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 1 October 2021].

https://www.medicines.org.uk/emc/medicine/33000>

Drugs, H., 2021. Olmesartan: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 1 October 2021].

https://medlineplus.gov/druginfo/meds/a603006.html>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 21 Oct 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.